Literature DB >> 11254952

Identification of Leishmania major cysteine proteinases as targets of the immune response in humans.

S Rafati1, A H Salmanian, K Hashemi, C Schaff, S Belli, N Fasel.   

Abstract

In this study, we report the identification of two parasite polypeptides recognized by human sera of patients infected with Leishmania major. Isolation and sequencing of the two genes encoding these polypeptides revealed that one of the genes is similar to the L. major cathepsin L-like gene family CPB, whereas the other gene codes for the L. major homologue of the cysteine proteinase a (CPA) of L. mexicana. By restriction enzyme digestion of genomic DNA, we show that the CPB gene is present in multiple copies in contrast to the cysteine proteinase CPA gene which could be unique. Specific antibodies directed against the mature regions of both types expressed in Escherichia coli were used to analyze the expression of these polypeptides in different stages of the parasite's life cycle. Polypeptides of 27 and 40 kDa in size, corresponding to CPA and CPB respectively, were detected at higher level in amastigotes than in stationary phase promastigotes. Purified recombinant CPs were also used to examine the presence of specific antibodies in sera from either recovered or active cases of cutaneous leishmaniasis patients. Unlike sera from healthy uninfected controls, all the sera reacted with recombinant CPA and CPB. This finding indicates that individuals having recovered from cutaneous leishmaniasis or with clinically apparent disease have humoral responses to cysteine proteinases demonstrating the importance of these proteinases as targets of the immune response and also their potential use for serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254952     DOI: 10.1016/s0166-6851(00)00377-7

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  19 in total

1.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.

Authors:  Michael C Myers; Parag P Shah; Mary Pat Beavers; Andrew D Napper; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2008-05-01       Impact factor: 2.823

2.  Molecular docking of cathepsin L inhibitors in the binding site of papain.

Authors:  Mary Pat Beavers; Michael C Myers; Parag P Shah; Jeremy E Purvis; Scott L Diamond; Barry S Cooperman; Donna M Huryn; Amos B Smith
Journal:  J Chem Inf Model       Date:  2008-07-04       Impact factor: 4.956

3.  Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major.

Authors:  Somayeh Zarrati; Mehdi Mahdavi; Fatemeh Tabatabaie
Journal:  J Parasit Dis       Date:  2014-08-31

4.  Identification of Leishmania species causing cutaneous leishmaniasis using Random Amplified Polymorphic DNA (RAPD-PCR) in Kharve, Iran.

Authors:  Fatemeh Saadabadi; Masoud Mohajery; Elham Poostchi; Seyyed Ali Akbar Shamsian
Journal:  Rep Biochem Mol Biol       Date:  2013-04

5.  Cloning of a Recombinant Plasmid Encoding Thiol-Specific Antioxidant Antigen (TSA) Gene of Leishmania majorand Expression in the Chinese Hamster Ovary Cell Line.

Authors:  Ghaffarifar Fatemeh; Tabatabaie Fatemeh; Sharifi Zohreh; Dalimiasl Abdolhosein; Hassan Mohammad Zahir; Mahdavi Mehdi
Journal:  Malays J Med Sci       Date:  2012-01

6.  Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  Hervé Pascalis; Anne Lavergne; Eliane Bourreau; Ghislaine Prévot-Linguet; Amina Kariminia; Roger Pradinaud; Sima Rafati; Pascal Launois
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Development and Assessment of Leishmania major and Leishmania tropica Specific Loop-Mediated Isothermal Amplification Assays for the Diagnosis of Cutaneous Leishmaniasis in Tunisia.

Authors:  Melek Chaouch; Karim Aoun; Souad Ben Othman; Meriem Ben Abid; Ines Ben Sghaier; Aida Bouratbine; Souha Ben Abderrazak
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

8.  Cysteine proteinases from promastigotes of Leishmania (Viannia) braziliensis.

Authors:  Karina M Rebello; Luzia M C Côrtes; Bernardo A S Pereira; Bernardo M O Pascarelli; Suzana Côrte-Real; Léa C Finkelstein; Rosa T Pinho; Claudia M d'Avila-Levy; Carlos R Alves
Journal:  Parasitol Res       Date:  2009-09-24       Impact factor: 2.289

9.  Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice.

Authors:  Mohammad Reza Mohammadi; Majid Zeinali; Sussan K Ardestani; Amina Kariminia
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

10.  Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis.

Authors:  Noushin Saljoughian; Tahereh Taheri; Farnaz Zahedifard; Yasaman Taslimi; Fatemeh Doustdari; Azam Bolhassani; Delaram Doroud; Hiva Azizi; Kazem Heidari; Mohammad Vasei; Nabiollah Namvar Asl; Barbara Papadopoulou; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.